In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

Biologic Pharmamedical invites wellness brands, MLMs, and co-manufacturers to explore how these patented technologies can revolutionize their product lines. From formulation to marketing, Biologic ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.